Rchr
J-GLOBAL ID:200901011378969433   Update date: Apr. 29, 2024

Kondoh Masuo

Kondoh Masuo
Affiliation and department:
Job title: Professor
Homepage URL  (1): https://masuo0.wixsite.com/rsphsosakauniv
Research field  (2): Pharmaceuticals - health and biochemistry ,  Clinical pharmacy
Research theme for competitive and other funds  (24):
  • 2022 - 2025 脳部位特異性を有する次世代脳内薬物送達システムの開発
  • 2020 - 2024 Development of the integrated therapeutic strategy aiming toward drug discovery and pharmacotherapy for treatment-resistant schizophrenia
  • 2022 - 2024 医療機器の情報共有による患者中心の医療イノベーションに関する研究
  • 2022 - 2023 患者フレンドリーな次世代経皮薬物送達技術の開発
  • 2019 - 2022 低分子・高分子・ナノ医薬品の脳部位特異的送達システムの開発
Show all
Papers (192):
  • Keisuke Tachibana, Ryuichi Hirayama, Naoyuki Sato, Kotaro Hattori, Takashi Kato, Hiroyuki Takeda, Masuo Kondoh. Association of Plasma Claudin-5 with Age and Alzheimer Disease. International journal of molecular sciences. 2024. 25. 3
  • Rina Fujiwara-Tani, Shiori Mori, Ruiko Ogata, Rika Sasaki, Ayaka Ikemoto, Shingo Kishi, Masuo Kondoh, Hiroki Kuniyasu. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy. International journal of molecular sciences. 2023. 24. 6
  • Koji Hosomi, Atsushi Shimoyama, Atsushi Hinenoya, Noritoshi Hatanaka, Takafumi Noguchi, Hirotaka Ebina, Yoko Tojima, Mari Furuta, Masuo Kondoh, Hiroshi Kiyono, et al. Endotoxin-Free Stx2B-C-CPE Vaccine and Its Optimized Adjuvant Regimen for Preventing Food Poisoning. Frontiers in Bioscience-Landmark. 2023. 28. 1. 15-15
  • Yoshitaka Shirasago, Hidesuke Fukazawa, Shotaro Nagase, Yoshimi Shimizu, Tomoharu Mizukami, Takaji Wakita, Tetsuro Suzuki, Hideki Tani, Masuo Kondoh, Takuya Kuroda, et al. A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection. Scientific reports. 2022. 12. 1. 20243-20243
  • Lin Bai, Keisuke Tachibana, Michika Murata, Tetsunori Inoue, Hiroyuki Mizuguchi, Shinichiro Maeda, Kenji Ikemura, Masahiro Okuda, Tetsuya Kusakabe, Masuo Kondoh. A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine. Toxicology letters. 2022. 370. 1-6
more...
MISC (221):
  • 村岡康介, 白倉圭佑, 船津梨彩, 井上采人, 土井健史, 竹田浩之, 橘敬祐, 近藤昌夫, 藤尾慈, 岡田欣晃. Development of intracerebral drug delivery technology using Claudin-5 binding molecules. 日本分子生物学会年会プログラム・要旨集(Web). 2021. 44th
  • 安藤大介, 山本栄一, QUAN Ying-shu, 近藤昌夫, 岡田直貴, 伊豆津健一. A Review of the Manufacturing Methods and Quality Attributes for Microneedle Array Development. 医薬品医療機器レギュラトリーサイエンス. 2021. 52. 5
  • 松下俊介, 橘敬祐, 日下部哲也, 日下部哲也, 堤康央, 近藤昌夫. Regulatory Considerations of Conditional Approval for Balancing Pre-market and Post-market Evaluations to Achieve Early Patient Access to Medical Products in Japan. レギュラトリーサイエンス学会誌. 2021. 11. 2
  • 庄真喜子, 橘敬祐, 原田和生, 平田收正, 堤康央, 國澤純, 國澤純, 國澤純, 國澤純, 國澤純, et al. Current situation and challenges of a regulatory concept of pharmacokinetics focusing on microbiome. 腸内細菌学雑誌. 2021. 35. 2
  • 若山英里香, 橘敬祐, 竹田浩之, 近藤昌夫. Development of regulatory science platforms for the central nervous system. 日本薬学会年会要旨集(CD-ROM). 2020. 140th
more...
Patents (11):
Books (1):
  • ペプチド・タンパク性医薬品の新規DDS製剤の開発と応用「第1章第5項 Claudin modulatorを用いたペプチド・タンパク性医薬品の経粘膜吸収促進」
    メディカルドゥ 2011
Education (2):
  • - 1998 Osaka University
  • - 1998 Osaka University Graduate School, Division of Pharmaceutical Sciences
Work history (9):
  • 2023/04 - 現在 Osaka University
  • 2018/04 - 現在 Professor,Drug Innovation Center, Graduate School of Pharmaceutical Sciences, Osaka University
  • 2015/04 - 2107/03 厚生労働省 医政局 研究開発振興課 臨床研究推進指導官
  • 2017/04 - 2018/03 厚生労働省 医薬・生活衛生局 医療機器審査管理課 医療機器審査調整官
  • 2012/04/01 - 2015/03/31 Osaka University Graduate School of Pharmaceutical Sciences Medical Pharmacy Associate Professor
Show all
Awards (6):
  • 2019/07 - 日本DDS学会 第19回日本DDS学会永井賞
  • 2011/08 - 国立大学法人 大阪大学 平成23年大阪大学功績賞
  • 2010/02 - The German Chamber of Commerce and Industry in Japan German Innovation Award, Gottfried Wagener Prize 2009 Award 3rd prize
  • 2009/07 - 日本DDS学会 日本DDS学会奨励賞
  • 2009/05 - 社団法人 日本薬剤学会 日本薬剤学会奨励賞
Show all
Association Membership(s) (1):
American Society for Pharmacology & Experimental Therapeutics
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page